| Issue Date | Title | Author(s) |
| 2020-05-19 | Genome-Wide Association Meta-Analysis of Single-Nucleotide Polymorphisms and Symptomatic Venous Thromboembolism during Therapy for Acute Lymphoblastic Leukemia and Lymphoma in Caucasian Children. | Mateos, MK; Tulstrup, M; Quinn, MC; Tuckuviene, R; Marshall, GM; Gupta, R; Mayoh, C; Wolthers, BO; Barbaro, PM; Ruud, E; Sutton, R; Huttunen, P; Revesz, T; Trakymiene, SS; Barbaric, D; Tedgård, U; Giles, JE; Alvaro, F; Jonsson, OG; Mechinaud, F; Saks, K; Catchpoole, D; Kotecha, RS; Dalla-Pozza, L; Chenevix-Trench, G; Trahair, TN; MacGregor, S; Schmiegelow, K |
| 2020-01 | Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against <i>MYCN</i>-Amplified Neuroblastoma. | Bellamy, J; Szemes, M; Melegh, Z; Dallosso, A; Kollareddy, M; Catchpoole, D; Malik, K |
| 2017-05-09 | Correction: LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma. | Vieira, GC; Chockalingam, S; Melegh, Z; Greenhough, A; Malik, S; Szemes, M; Park, JH; Kaidi, A; Zhou, L; Catchpoole, D; Morgan, R; Bates, DO; Gabb, PJ; Malik, K |
| 2021-02-06 | Transcriptomic Analyses of MYCN-Regulated Genes in Anaplastic Wilms' Tumour Cell Lines Reveals Oncogenic Pathways and Potential Therapeutic Vulnerabilities. | Szemes, M; Melegh, Z; Bellamy, J; Park, JH; Chen, B; Greenhough, A; Catchpoole, D; Malik, K |
| 2015-11-24 | LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma. | Vieira, GC; Chockalingam, S; Melegh, Z; Greenhough, A; Malik, S; Szemes, M; Park, JH; Kaidi, A; Zhou, L; Catchpoole, D; Morgan, R; Bates, DO; Gabb, PD; Malik, K |
| 2015-03 | Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells. | Park, JH; Szemes, M; Vieira, GC; Melegh, Z; Malik, S; Heesom, KJ; Von Wallwitz-Freitas, L; Greenhough, A; Brown, KW; Zheng, YG; Catchpoole, D; Deery, MJ; Malik, K |
| 2018-11-15 | Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma. | Wei, JS; Kuznetsov, IB; Zhang, S; Song, YK; Asgharzadeh, S; Sindiri, S; Wen, X; Patidar, R; Najaraj, S; Walton, A; Auvil, JMG; Gerhard, DS; Yuksel, A; Catchpoole, D; Hewitt, SM; Sondel, PM; Seeger, R; Maris, JM; Khan, J |
